Target
Nuclear receptor ROR-gamma [262-507]
Ligand
BDBM327563
Substrate
n/a
Meas. Tech.
Spa Binding Assay
IC50
16.9±n/a nM
Citation
 Dhar, TGDuan, JGong, HJiang, BLu, ZWeinstein, DS RORγ modulators US Patent  US9663469 Publication Date 5/30/2017 
Target
Name:
Nuclear receptor ROR-gamma [262-507]
Synonyms:
NR1F3 | Nuclear receptor ROR-gamma | Nuclear receptor ROR-gamma (aa 262-507) | ROR-gamma (A262-S507) | RORC | RORG | RORG_HUMAN | RZRG
Type:
Enzyme Catalytic Domain
Mol. Mass.:
28605.37
Organism:
Homo sapiens (Human)
Description:
aa 262-507
Residue:
246
Sequence:
APYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS
  
Inhibitor
Name:
BDBM327563
Synonyms:
US9663469, 102 | US9663469, 120 | US9663469, 121
Type:
Small organic molecule
Emp. Form.:
C24H23F7N2O6S
Mol. Mass.:
600.503
SMILES:
O[C@@H]1COC[C@H]1NC(=O)C[C@@H]1CCc2cc(ccc2N1S(=O)(=O)c1ccc(F)cc1)C(O)(C(F)(F)F)C(F)(F)F |r|
Structure:
Search PDB for entries with ligand similarity: